Beam stock forecast.

The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)

Beam stock forecast. Things To Know About Beam stock forecast.

Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ... Drug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)

Beam Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 28, 2023 4:20 p.m. EST Delayed quote $ 29.77 0.00 0.00% After Hours Volume: 14.9K Advanced Charting Volume:...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Steel beams are a crucial component in construction projects, providing structural support for buildings, bridges, and other infrastructure. However, not all steel beams are created equal.3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.Box, Inc. (NYSE:BOX) announced its earnings results on Tuesday, August, 29th. The software maker reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.01. The software maker earned $261.43 million during the quarter, compared to analyst estimates of $261.32 million.Tritium shares are priced at $6.34 and their average price target of $14.40 implies an upside potential of ~127%. ( See Tritium stock forecast on TipRanks) Beam Global, the second EV charging ...

Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)

A weaver’s beam, or warp beam, varies in size depending on the design and size of the loom it fits. A warp beam is the part of a loom where the warp ends are placed when preparing to weave.

SMM Review and Outlook of Copper and Aluminum Market in 2023-2024. Nov 29, 2023 17:35. UBS Base Metals Outlook 2024: Copper Will See A Supply Deficit, Aluminum Prices Will Be Higher Later In 2024, Lead And Zinc Will Be In Small Surplus ... LME, SHFE and COMEX copper stocks all hit multi-month low, with SHFE copper …As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Dec 1, 2023 · Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis. Find the latest Beam Global (BEEM) stock quote, history, news and other vital information to help you with your stock trading and investing.

Strong Buy Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile 3m (25.40%) 12m (-35.51%) Bollinger Bands …Nov 29, 2023 · The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ... Dec 1, 2023 · Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more. Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ... Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.

Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes, company profile, news and forecasts from CNN Business.BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I take profit in Beam ...

Ouster (NYSE: OUST) While its ticker symbol sounds ominous, Ouster LiDAR stocks could have a bright future ahead, especially within the next few years. This San Francisco-based company produces …When is Beam Global's earnings date? Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.Nov 1, 2023 · Stock Forecast for the Price of an Beam Therapeutics Share in Jan 2025. In January 2025, analysts believe the stock price will be $21.77. An increase of 14.09% compared to the previous month's estimate. Stock Price Forecast. Posted on January 30 2021 by Sandra. Beam Therapeutics stock stood at 572999992370605 on 2022-03-31. According to 13 stock analysts the average 12-month stock price forecast for Beam Global stock is 2652 which predicts an increase of 7931. Introducing beam global nasdaq beem 10 top 5g stocks for 2021 discover the …Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.Global whiskey market: leading brands based on sales volume 2022. In 2022, some 30.8 million 9 liter cases of McDowell's No. 1 whiskey were sold worldwide. Royal Stag was number two that year ...

Find real-time MELI - MercadoLibre Inc stock quotes, company profile, news and forecasts from CNN Business.

In 2021, Vertex acquired the rights to 60% of the profits from sales of Crispr Therapeutics gene-editing therapy CTX001, now called exa-cel, for up to $1.1 billion, pending regulatory approval ...

Find the latest Ion Beam Applications SA (IBAB.BR) stock quote, history, news and other vital information to help you with your stock trading and investing.Beam Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 28, 2023 4:20 p.m. EST Delayed quote $ 29.77 0.00 0.00% After Hours Volume: 14.9K Advanced Charting Volume:...Their consensus HOOD stock forecast was that it could hit $13.36, which would represent a potential upside of 39.28% over the $9.59 closing price on 20 November, 2022. The highest Robinhood stock forecast 2023 prediction came in at $28 and the lowest warned it could slip to just $7. HOOD stock was also a ‘hold’, according to the …The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ...Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year).Find the latest Quantum-Si incorporated (QSI) stock quote, history, news and other vital information to help you with your stock trading and investing.Meanwhile, Cathie Wood has been adding more BEAM shares to the ARKG ETF. During January, she purchased 163,838 shares. The ETF now hold 2,126,439 shares in total, currently worth ~$92.4 million ...7 brokerages have issued 1 year target prices for Verve Therapeutics' stock. Their VERV share price targets range from $13.00 to $55.00. On average, they expect the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 147.5% from the stock's current price. View analysts price targets for VERV or view top ...

Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …Instagram:https://instagram. jepi newsforex trade signalsbest shorted stocksmt5 brokers usa Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...BEEM Stock 12 Months Forecast. $24.00. (228.09% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Beam Global in the last 3 months. The average price target is $24.00 with a high forecast of $40.00 and a low forecast of $12.00. The average price target represents a 228.09% change from the last price of $7.32. trading ideabest day trading companies Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.Get the latest Lumber price (LBR) as well as the latest futures prices and other commodity market news at Nasdaq. oil prices drop Nov 28, 2023 · Analyst Forecast. According to 2 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price forecast is $6.78, which is an increase of 361.22% from the latest price. BEAM - Beam Therapeutics Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ...